{"id":"https://openalex.org/W4281617331","doi":"https://doi.org/10.1001/jamanetworkopen.2022.16058","title":"Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022","display_name":"Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022","alternate_titles":[],"publication_year":2022,"publication_date":"2022-06-10","ids":{"openalex":"https://openalex.org/W4281617331","doi":"https://doi.org/10.1001/jamanetworkopen.2022.16058","pmid":"https://pubmed.ncbi.nlm.nih.gov/35687338","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9187950"},"language":"en","primary_location":{"id":"doi:10.1001/jamanetworkopen.2022.16058","doi":"https://doi.org/10.1001/jamanetworkopen.2022.16058","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamanetworkopen.2022.16058","pdf_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793228/mousavi_2022_oi_220467_1654263497.52435.pdf","source":{"id":"https://openalex.org/S4210217848","display_name":"JAMA Network Open","issn_l":"2574-3805","issn":["2574-3805"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Network Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4281617331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793228/mousavi_2022_oi_220467_1654263497.52435.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090724240","display_name":"Idine Mousavi","orcid":"https://orcid.org/0000-0001-7120-9352","observed_orcids":["https://orcid.org/0000-0001-7120-9352"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Idine Mousavi","raw_affiliation_strings":["School of Medicine, New York Medical College, Valhalla"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, New York Medical College, Valhalla","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005844055","display_name":"Timoth\u00e9e Olivier","orcid":"https://orcid.org/0000-0002-6936-5783","observed_orcids":["https://orcid.org/0000-0002-6936-5783"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Timoth\u00e9e Olivier","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco","Department of Oncology, Geneva University Hospital, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Oncology, Geneva University Hospital, Geneva, Switzerland","institution_ids":["https://openalex.org/I4210106256"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007770903","display_name":"Vinay K. Prasad","orcid":"https://orcid.org/0000-0002-6110-8221","observed_orcids":["https://orcid.org/0000-0002-6110-8221"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vinay Prasad","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007770903"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":2.3694,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.89611385,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"5","issue":"6","first_page":"e2216058","last_page":"e2216058"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.042399998754262924,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8109999895095825},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.4749999940395355},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.8259999752044678},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8230000138282776},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9020000100135803},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.9610000252723694},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6430000066757202},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.4819999933242798},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.7590000033378601},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.515999972820282},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5490000247955322},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.6125210523605347},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5159388184547424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48892679810523987},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4276679456233978},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41061779856681824},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3575495779514313},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.33543673157691956},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.08553817868232727},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1001/jamanetworkopen.2022.16058","doi":"https://doi.org/10.1001/jamanetworkopen.2022.16058","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamanetworkopen.2022.16058","pdf_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793228/mousavi_2022_oi_220467_1654263497.52435.pdf","source":{"id":"https://openalex.org/S4210217848","display_name":"JAMA Network Open","issn_l":"2574-3805","issn":["2574-3805"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Network Open","raw_type":"journal-article"},{"id":"pmid:35687338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35687338","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA network open","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9187950","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9187950/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Netw Open","raw_type":"Text"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt73b685j4","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/73b685j4","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA Network Open, vol 5, iss 6","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1001/jamanetworkopen.2022.16058","doi":"https://doi.org/10.1001/jamanetworkopen.2022.16058","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamanetworkopen.2022.16058","pdf_url":"https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793228/mousavi_2022_oi_220467_1654263497.52435.pdf","source":{"id":"https://openalex.org/S4210217848","display_name":"JAMA Network Open","issn_l":"2574-3805","issn":["2574-3805"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Network Open","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315359","display_name":"Arnold Ventures","ror":null},{"id":"https://openalex.org/F4320332622","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4281617331.pdf","grobid_xml":"https://content.openalex.org/works/W4281617331.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1810662963","https://openalex.org/W2266198524","https://openalex.org/W2600333833","https://openalex.org/W2618058692","https://openalex.org/W2752210999","https://openalex.org/W2753065806","https://openalex.org/W2902218997","https://openalex.org/W2916828939","https://openalex.org/W3006930853","https://openalex.org/W3021316203","https://openalex.org/W3032530102","https://openalex.org/W3087210493","https://openalex.org/W3148827278","https://openalex.org/W3153228158","https://openalex.org/W3155554393","https://openalex.org/W3163995648","https://openalex.org/W3165576985","https://openalex.org/W3194548803","https://openalex.org/W3196207248","https://openalex.org/W3199241644"],"related_works":["https://openalex.org/W4416951272","https://openalex.org/W3029375629","https://openalex.org/W4388198357","https://openalex.org/W2093982357","https://openalex.org/W4394891568","https://openalex.org/W3007239545","https://openalex.org/W2167727926","https://openalex.org/W2922151184","https://openalex.org/W2981156554","https://openalex.org/W7212003423"],"abstract_inverted_index":{"Importance:":[0],"Adjuvant":[1],"therapies":[2,23],"are":[3],"often":[4],"approved":[5,41,334],"based":[6,263,335],"on":[7,264,336],"improvements":[8],"in":[9,21,88,139,169,196,212,235,251,292,329],"disease-,":[10,337],"progression-,":[11,338],"or":[12,340,359,366],"relapse-free":[13,341],"survival":[14,282],"(ie,":[15],"an":[16,280],"event).":[17],"An":[18],"important":[19],"estimate":[20],"adjuvant":[22,90,294,313,331],"is":[24],"the":[25,33,43,69,75,89,131,144,154,157,162,170,183,189,216,222,229,238,252,270,293,330],"cost":[26,204,218,223,286,309],"per":[27,35,180,205,224,287,318,344],"event":[28,36,206,288,345],"averted.":[29],"Objective:":[30],"To":[31],"characterize":[32],"costs":[34,124,179],"averted":[37,207,289,346],"of":[38,92,96,125,156,161,174,219,246,290,310],"anticancer":[39,85,327],"drugs":[40,86,291,354],"by":[42],"US":[44],"Food":[45],"and":[46,53,58,102,111,116,182,201,241,321],"Drug":[47],"Administration":[48],"(FDA)":[49],"between":[50,108],"January":[51,109,255],"2018":[52,110,256],"March":[54,112,197,258],"2022.":[55,198],"Design,":[56],"Setting,":[57],"Participants:":[59],"In":[60,323],"this":[61,324],"cross-sectional":[62,325],"study,":[63,326],"all":[64,260],"approvals":[65,248,261],"were":[66,105,114,128,141,194,249,262,333,347],"reviewed":[67],"from":[68,81,130,143],"FDA":[70],"website.":[71],"Approvals":[72,107],"selected":[73],"for":[74,150,188,208,226],"analysis":[76],"needed":[77,185],"to":[78,186,257,278,303],"be":[79],"drawn":[80],"randomized":[82],"trials":[83,104,118,276],"involving":[84],"studied":[87,211,234],"treatment":[91,314],"solid":[93],"tumors.":[94],"Treatments":[95],"nonsolid":[97],"tumors;":[98],"nonrandomized,":[99],"noncontrolled":[100],"trials;":[101],"unpublished":[103],"excluded.":[106],"2022":[113],"included,":[115],"11":[117,247],"met":[119],"inclusion":[120],"criteria.":[121],"The":[122,203,284,307],"monthly":[123,178,217],"each":[126,151,209,213,220,227,236],"agent":[127,210],"abstracted":[129,149],"Micromedex":[132],"RED":[133],"BOOK":[134],"database.":[135],"All":[136],"variables":[137],"included":[138,153,250],"calculations":[140],"derived":[142],"original":[145],"trial":[146],"publication.":[147],"Information":[148],"approval":[152],"name":[155,160],"drug":[158],"approved,":[159],"trial,":[163,171],"primary":[164,190,230,271],"end":[165,191,232,267,272],"point,":[166,273],"dosing":[167],"regimen":[168],"median":[172,285,308],"duration":[173],"treatment,":[175],"tumor":[176],"type,":[177],"drug,":[181,221,228],"number":[184],"treat":[187],"point.":[192],"Data":[193],"analyzed":[195],"Main":[199],"Outcomes":[200],"Measures:":[202],"clinical":[214,231],"trial;":[215,237],"patient":[225],"point":[233,268],"study's":[239],"design":[240],"setting.":[242],"Results:":[243],"A":[244],"total":[245],"study.":[253],"From":[254],"2022,":[259],"a":[265,311],"surrogate":[266],"as":[269],"with":[274],"no":[275],"demonstrating,":[277],"date,":[279],"overall":[281],"benefit.":[283],"setting":[295,332],"was":[296,315],"$1":[297],"610":[298],"000":[299,302,317],"(range,":[300],"$820":[301],"$2":[304],"640":[305],"000).":[306],"complete":[312],"$158":[316],"patient.":[319],"Conclusions":[320],"Relevance:":[322],"agents":[328],"event-,":[339],"survival.":[342],"Costs":[343],"high.":[348],"These":[349],"findings":[350],"suggest":[351],"that":[352],"these":[353],"may":[355],"not":[356],"achieve":[357],"wide":[358],"global":[360],"use":[361],"unless":[362],"their":[363,367],"efficacy":[364],"improves":[365],"prices":[368],"decrease.":[369]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4281617331","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-06-13T00:00:00"}
